CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Yocca Frank Chief Scientific Officer | Option exercise | +521 | 10,017 | ||
| 2023-06-14 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −521 | 5,732 | ||
| 2023-06-14 | Steinhart Richard I Chief Financial Officer | Option exercise | +521 | 2,021 | ||
| 2023-06-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −521 | 5,732 | ||
| 2023-06-14 | Mehta Vimal CEO and President | Option exercise 10b5-1 | +2,609 | 39,903 | ||
| 2023-06-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −2,609 | 28,704 | ||
| 2023-06-14 | O'Neill Vincent Chief Medical Officer | Option exercise | +521 | 1,760 | ||
| 2023-06-14 | O'Neill Vincent Chief Medical Officer | Option exercise · Restricted Stock Units | −521 | 5,732 | ||
| 2023-05-22 | Mehta Vimal CEO and President | Sale 10b5-1 | −6,500 | $25.79 | $168K | 37,294 |
| 2023-05-15 | Steinhart Richard I Chief Financial Officer | Sale 10b5-1 | −5,000 | $27.17 | $136K | 1,500 |
| 2023-05-15 | Rodriguez Javier See Remarks | Sale 10b5-1 | −1,785 | $27.32 | $49K | 4,350 |
| 2023-05-14 | Mehta Vimal CEO and President | Option exercise | +15,000 | 30,894 | ||
| 2023-05-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units | −15,000 | 0 | ||
| 2023-05-14 | Steinhart Richard I Chief Financial Officer | Option exercise 10b5-1 | +5,000 | 6,500 | ||
| 2023-05-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 0 | ||
| 2023-05-14 | Rodriguez Javier See Remarks | Option exercise 10b5-1 | +5,000 | 6,135 | ||
| 2023-05-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 0 | ||
| 2023-04-06 | Nandabalan Krishnan Director | Option exercise 10b5-1 | +60,000 | $0.41 | $25K | 60,000 |
| 2023-04-06 | Nandabalan Krishnan Director | Sale 10b5-1 | −60,000 | $17.32 | $1.0M | 0 |
| 2023-04-06 | Nandabalan Krishnan Director | Option exercise · Stock Options 10b5-1 | −60,000 | 294,000 |
Page 18 of 27 · 521 trades